Small Molecule Kinase Inhibitors

Global Market Trajectory & Analytics

MCP-1723

EXECUTIVE ENGAGEMENTS

POOL

5511
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

882
Interactions with Platform & by Email

PARTICIPANTS

163
Unique # Participated

VALIDATIONS

36
Responses Validated*

COMPANIES

83
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

66

PAGES

179

EDITION

19

PRICE

USD 5450

CODE

MCP-1723


COMPETITIVE METRICS

COMPANY

D S N T

% *

Actelion Pharmaceuticals Ltd.

Advenchen Laboratories

Ambit Biosciences

AMETEK, Inc.

AstraZeneca PLC

Bachem AG

Boehringer Ingelheim International GmbH

Bristol-Myers Squibb Company

Celgene Corporation

CGI Pharmaceuticals

View More...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Small Molecule Kinase Inhibitors estimated at US$32.9 Billion in the year 2020, is projected to reach a revised size of US$70.3 Billion by 2027, growing at a CAGR of 11.5% over the period 2020-2027.
The Small Molecule Kinase Inhibitors market in the U.S. is estimated at US$8.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$15.2 Billion by the year 2027 trailing a CAGR of 15.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8% and 9.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9% CAGR.

SELECT PLAYERS

A-Laskuvarjo; Aries S.A.; ATECH Inc.; Bney Meir Ltd.; Curtiss-Wright Corporation; ESCRIBANO Mechanical and Engineering; General Atomics; QinetiQ North America; Scama AB; Wire Rope Industries; Wireco WorldGroup

SEGMENTS

» Small Molecule Kinase Inhibitors

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
ACTELION PHARMACEUTICALS LTD.
UNITED STATES
USA Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
ASTRAZENECA PLC
CANADA
Canada Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
JAPAN
Japan Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
BRISTOL-MYERS SQUIBB COMPANY
CHINA
China Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
CELGENE CORPORATION
EUROPE
Europe Current & Future Analysis for Small Molecule Kinase Inhibitors by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for Small Molecule Kinase Inhibitors by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Small Molecule Kinase Inhibitors by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
ENZO LIFE SCIENCES, INC.
FRANCE
France Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
EXELIXIS, INC.
GERMANY
Germany Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
GENENTECH, INC.
ITALY
Italy Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
H. LUNDBECK A/S
UNITED KINGDOM
UK Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
INCYTE CORPORATION
SPAIN
Spain Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
KAMIYA BIOMEDICAL COMPANY
RUSSIA
Russia Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
NOVARTIS AG
REST OF EUROPE
Rest of Europe Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
PROMOCELL GMBH
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Small Molecule Kinase Inhibitors by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Small Molecule Kinase Inhibitors by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Small Molecule Kinase Inhibitors by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
TAKARA BIO, INC.
AUSTRALIA
Australia Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TOCRIS BIOSCIENCE
INDIA
India Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
India Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
SOUTH KOREA
South Korea Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
LATIN AMERICA
Latin America Current & Future Analysis for Small Molecule Kinase Inhibitors by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Latin America Historic Review for Small Molecule Kinase Inhibitors by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Small Molecule Kinase Inhibitors by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
ARGENTINA
Argentina Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
BRAZIL
Brazil Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
MEXICO
Mexico Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
REST OF LATIN AMERICA
Rest of Latin America Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
MIDDLE EAST
Middle East Current & Future Analysis for Small Molecule Kinase Inhibitors by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Middle East Historic Review for Small Molecule Kinase Inhibitors by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Small Molecule Kinase Inhibitors by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
IRAN
Iran Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
ISRAEL
Israel Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
SAUDI ARABIA
Saudi Arabia Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UNITED ARAB EMIRATES
UAE Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
REST OF MIDDLE EAST
Rest of Middle East Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
AFRICA
Africa Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World Current & Future Analysis for Small Molecule Kinase Inhibitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Small Molecule Kinase Inhibitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Small Molecule Kinase Inhibitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com